Aptevo Therapeutics Inc.
APVO· Nasdaq
APVOAptevo Therapeutics Inc.
Filed Mar 5, 2024 · 10-K · 65 days after period end · 0000950170-24-025428
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $0.00 | $3.67M | — |
| Net Income | -$5.90M | -$4.64M | -$6.27M | -$7.05M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aptevo Therapeutics Inc. · CIK 1671584 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Mar 5, 2024 · 65 d after period end
